Member Info for bignose58

With ref to your post on the 15th March where you wrote:

"I don’t think his salary is as big as you think and he hasn’t been taking any for a while", which clearly seems to be a response by JM to your email question on JGs salary.

Given that the Financial report clearly shows that JG is indeed still getting paid and at the same level definitely indicates that JM has no idea what his company is doing and who is being paid what. Also with ref to the preamble he made to the report, anyone would think he was referring to a different company when making the statement:

"Disappointing that profitability could not be achieved for 2018, this was due to the investment and resources allocated to the commercial launch of Fortacin in certain countries in the Europen Union earlier in the year coupled with the large amortisation cost of US$28.05 million".

I don't think anyone was expecting to even come close to break-even, let alone a profit. Notice there was no mention in the statement of the "disappointing sales"........ :-O

Do they really have the best interests of the shareholders ? Certainly makes one wonder doesn't it.

Sorry bunion for still being negative, but until there is some positive news which actually does indicate true shareholder value, I will still have my reservations on OUR employees ability to produce results in a professional manner.

Now to compose an email to our main employee asking why there is nothing in the report regarding the needed cash for the next 12 months.... LOL

bunion

Sorry to pour water on an already damp fire, but. Last September I emailed JG regarding the upcoming 5 launches that were announced to be launched by the end of 2018 I wanted to know if there was a possibility that Recordati may decide to delay due to the "disappointing sales". He responded that the launches would happen on schedule as per the announcement. Well we all know what happened then, i.e nothing. JG had no idea what was going to happen and didn't even have the intelligence to question Recordati himself. Either that or he deliberately provided inaccurate information.

The point I'm making is, JG historically has never been transparent with the company information and as such, we will never know the truth until it actually takes place.

Although most, myself included, are interested in the HK and Macau launches to see if a local launch has a positive effect on the SP, I am also concerned on whether the announced launches of Romania and Greece will take place later in the year or Recordati will again renege. If they do renege, that will definitely ring alarm bells on whether Recordati will pull the plug.

And to make sure the proxy vote is received on time.

In order for it to be valid, the form of proxy, accompanied by the power of attorney (if applicable) or other authority (if any) under which it is signed or a certified copy of that power or authority, must be deposited with the Company Secretary at the Company’s principal place of business in Hong Kong at 8th Floor, Henley Building, 5 Queen’s Road Central, Hong Kong not later than 11:00 am on Tuesday, 4 June 2019.

Just contacted my broker and set the wheels in motion. Think I was a bit quick to mention Stella. The shares are in a nominated account so I just instruct the broker to instruct the nominee to send the form in. :-)

After a quick look at the presentation.

Looks all nice n rosy, however...... another 3 years till we see FDA. another 4 till China. No mention of the difficulties of selling the product in Europe and no mention of us being strapped for cash, however ====>>>

To include the below is a deliberate attempt to mislead. None of this should be included since it was applicable during the days of a different company. They have nothing to do with the incompetence of the last 4 years which is reflected in the current share price.

Average cash returns generated over the term of investment of nearly two times on material investment disposals over the last 6.5 years from mid 2009 to 2015

In the 21 years of financial reporting since IPO, returned US$298 million to shareholders (US$239.3 million in
dividends and US$59.6 million in share buy-backs)

Morning Prof.

This was discussed a few months back. Some shareholders, including your good self, communicated their shareholding either by posting or by an email to myself (email address was posted) to see where we stood. 23 shareholders declared their holding with a total combined holding of 3.43% (I am still uncertain of Bothwell since he posted 2 holding figures within weeks of each other and never confirmed). Unfortunately, and we knew the answer from the very beginning, it was never going to be enough to do anything constructive since back then they required 25% to propose an EGM for us to be heard. Since then, the required number has been reduced to 20%, although I cannot for the life of me work out why they would reduce from 25 to 20% as it makes no difference.

That said, If we all get in quick we can fill in the proxy vote ticking the relevant box to not reinstate Jamie as CEO. It may not make any difference but with the much increased AGAINST vote on the usual FOR vote, it surely must not go unnoticed (Mind you, we may be very lucky and catch them with their pants down and have more AGAINST votes than those present to vote FOR - I don't think Jamie can vote for himself?). I suggest you name stella fung as your proxy (you prob will need to email her for her confirmation and willingness to act on your behalf stella fung at regentpac com) Proxy vote form can be found here: http://www.regentpac.com/template?series=17&year=2019

I also suggest you read the share holder communications document here:
http://www.regentpac.com/ICMServlet/download/174-1584-3096/ShareholdersCommunicationPolicy(English)-13Mar2012(FurtherRevised).pdf

As a 2nd possibility, you/we email Jim telling him that Jamie has to go and or his salary reduced by 75% to reflect his non performance. Although we may have 3 license agreements, the company is now worth less than when we didn't have any which tells us they are all considered less than worthless.

And a couple of final points.
There is now a new corporate presentation which was uploaded some time this month. (I have yet to read and comment on it).
http://www.regentpac.com/ICMServlet/download/18-2239-3645/(1A)CompanyOverview-RPGL(March2019)-English.pdf

Why is the DBC still listed under the business portfolio when the company sold its holding at approx. 90% loss some months ago ?

This may be of interest too:
Procedures for shareholders to propose a person for election as a Director of the Company:
http://www.regentpac.com/ICMServlet/download/174-1586-2867/Procedures-ShareholdersToProposeDirector(English)-13Mar2012(Revised).pdf

Morning The.Italian.

Obviously agree with some of your post, however. I am of the view that neither Fosun or Orient would have taken on a license agreement if they were not convinced they could sell the product. They have had a year to follow the progress of Recordati, which. although seems to be a joke and well unprepared given they had access to the 2006 German study, didn't stop them from signing. This surely must be seen as a positive. especially given the % Fosun will be paying Plethora and subsequently RPG. Maybe that's why they both waited till nearly the end of Dec. They wanted to see the expected final sales figures for the year, which RPG must have had info on at that time.

Just my opinion on things.

Unfortunately our problem is and will always be the incompetence of management. As I stated before; where else in the world would an SP dive after the release of news of a Chinese licensing agreement ? they are not doing their job and I see JG is still getting paid 1.5mill USD....Its a b00dy disgrace. That's currently 3.25% of the companies market cap !!!

Hi bunion.

Thanks for that, although I was already aware of it. I was just making the point that the sentence was the same as was announced last year b4 they signed the said agreement.

Its quite obvious now that they just don't have a clue as to what has been announced, what agreements they have made and what needs to be announced.

And they call themselves professionals....derrrr

So it would seem HK and Macau licenses have still not been agreed...page 25:

Consequently, the Company is now in discussions with possible
marketing and distribution partners to help facilitate the Macau and Hong Kong roll-out..

You just cannot make it up the incompetence of allowing such a statement after the fact. and remember the license agreement was made on 21st December, so no excuses that the year end report couldn't be updated.

Ohhhh and I forgot.

Regarding the recent posts on the "next spike". Although we have been advised that both Romania and Greece will be launched later in 2019, I don't expect to see any sparks fly as a result since there was no reaction to the E5 launches. I am sure HK and Macau will get a far better response than these 2, but then again...who knows, certainly not BigNose......LOL

Ohhh I forgot to add this:

http://www.regentpac.com/ICMServlet/download/15-2243-3653/EAnnualReport-RPGL(31Dec2018).pdf

I was just about to ask when we would see the annual report uploaded........ Just checked and there it is.

Right...... Ill have a quick read of the money situation.......gulp..... ;-)

I notice the SP bounced up n down to 0.25 today, so maybe it has further to go yet before the dreaded cash call is made......

I stand corrected. Revisiting my last post on the subject, the website showed 14 (sorry Jamie), however. Still strange they didn't update to show the remaining 3. It does make one wonder if there are still 3 to come given they have previously indicated others as "Not Yet Recruiting" ???

Last updated 23rd April.

Now all 17 centres are shown as recruiting:

Locations:
United States, Alabama
1 Achieve Clinical Research...........................................................Recruiting
2 Coastal Clinical Research...........................................................Recruiting
United States, California
3 San Diego Sexual Medicine, APC................................................Recruiting
United States, Florida
4 Imagine Research of Palm Beach County...................................Recruiting
5 Avail Clinical Research Recruiting
6 Clinical Research Center of Florida .............................................Recruiting
United States, Georgia
7 Primary Care Research Recruiting
8 Georgia Clinical Research, Llc......................................................Recruiting
United States, Indiana
9 First Urology..................................................................................Recruiting
United States, Louisiana
10 Regional Urology, LLC..................................................................Recruiting
United States, Nevada
11 Jubilee Clinical Research, Inc.......................................................Recruiting
United States, New York
12 Manhattan Medical Research Practice.........................................Recruiting
13 Premier Medical Group of the Hudson Valley...............................Recruiting
United States, North Carolina
14 M3 Wake Research, Inc...............................................................Recruiting
United States, Tennessee
15 Volunteer Research Group...........................................................Recruiting
United States, Utah
16 Advanced Clinical Research - Jordan Ridge Family Medicine.....Recruiting
17 Advanced Clinical Research.........................................................Recruiting

Interesting, still as I mentioned before. JG alluded that there are 20 centres, yet the gov website has always only shown 17. Seems like he cannot even get that right.

https://clinicaltrials.gov/ct2/show/NCT03578783

Oh... and incase anyone is wondering.

Deep Dive = An in-depth examination or analysis of a topic.

As appose to

Muff diving = Diving and being able to breathing through ones ears........LOL

PP

All good thanks.

Sitting twiddling my thumbs undecided what comes first the chicken(placing) or the egg (HK/Macau Launch). :-)

The only thing which is bothersome is as the SP declines so the dilution requirement increases to get ....what was it last time, about 5mill USD ? Currently dilution requirement stands at about 11%.... and that's just for this year. Hopefully the China syndrome will start the locomotion this year and we will receive the 4 mill to help lessen the cash call next year (unless Recordati can pull something out the bag with their muff diving....errr I mean Deep Diving. as advised by JG....LOL

Possibly the supposed HK and Macau launches. Although insignificant in value, the locals my react positively to them as a reason to have a short trading frenzy.

In about 2 to 3 months, if the schedule can be kept, which as we all know are moving targets when it comes to announcements made by JG (alias Billy Liar).

Bothwell,

I don't think its a case of "not early enough for some". Many have been invested here for several years, and I mean more than seven. In that time we have had announcements of new license agreements (after the Recordati one) being at heads of terms since 2014. In fact doesn't it make you wonder why when they stated that further licenses could be signed by the end of 2014 only to see the first one being signed 4 years later in Dec 2018 to China which was not even on the cards in June 2016. JGs words to me then were something along the lines of "We wont be considering a Chinese license since it will take too long". Now maybe you can clarify what changed ? why did it change ? What happened to all the other licenses they announced were at heads of terms all those years ago. It surely could not have been only the Orient one since they mentioned other regions.

What about four or five different announcement dates of FDA approval ? And that's after the "unambiguous agreement" announcement in 2014. Surely if there was an unambiguous agreement, we would have started the trials long before Dec 2018. They cannot even get something as simple as that right. August 2018 I was informed by JG they had indeed started the trials in August when in fact we were later informed they were delayed till Dec !!! What an utter untrustworthy and unprofessional person.

I really think you should be a little more empathic to those who have rightly become somewhat impatient given the expectations created through the companies own announcements. Not once but many times over.

You are correct, it will come good, but it would taste a lot lot better if management had not deliberately lied and misled shareholders through their own mishandling of events, lack of transparency and amateurish projections. Everyone understands Pharma takes a long time, but the company has never once given any reasons as to why they have never managed to keep to their own projected timelines. Its no wonder why many shareholders are expressing their frustrations.

The.Italian
You are probably not far off the truth there. He cannot quite make the GBP billionaires club, not for the lack of trying, and he realises he will need to live much longer to become a member.... Lol

Very true, but will it happen whilst most of us are still alive n kicking ???